Nuwellis has been granted a patent for an extracorporeal blood filtering machine with advanced features like blood circuit, effluent circuit, and source fluid circuit controlled by a controller. The machine includes sensors for accurate operation, a user interface, and automatic emptying of medical fluid containers. GlobalData’s report on Nuwellis gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Nuwellis, Remote monitored dialysis machines was a key innovation area identified from patents. Nuwellis's grant share as of May 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.
Extracorporeal blood filtering machine with controlled fluid flow
A recently granted patent (Publication Number: US11998673B1) discloses an extracorporeal blood filtering machine designed to efficiently remove waste from a patient's blood. The machine comprises a blood circuit with a blood line, filter, and blood pump, a source fluid circuit with a source fluid line and pump, and an effluent circuit with an effluent line and pump. The machine also includes sensors to measure source fluid and effluent flow quantities, with a controller operating the machine in open-loop or closed-loop modes. In the closed-loop mode, the controller adjusts pump speeds based on flow quantities, utilizing an effluent receptacle that can switch between a drain and a bag based on the operational mode.
Furthermore, the patent includes additional claims related to sensors measuring effluent weight values, fluid volumes, and secondary flow quantities in the source fluid and effluent lines. The controller is configured to compare these measurements and issue alerts if discrepancies exceed set thresholds. Additionally, the controller can switch between open-loop and closed-loop modes based on user input, providing flexibility in operation. Overall, the extracorporeal blood filtering machine described in the patent aims to enhance efficiency and accuracy in blood filtration processes, ensuring optimal waste removal and patient safety during extracorporeal treatments.
To know more about GlobalData’s detailed insights on Nuwellis, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
